Results 71 to 80 of about 236,404 (264)

Candida glabrata és Candida tropicalis izolátumok szaporodásának in vitro gátlása caspofungin és nikkomycin-Z jelenlétében

open access: yes, 2010
Napjainkban egyre nő az invazív és nem invazív, sarjadzó gombák által okozott fertőzések száma, melyek kialakulásában számos tényező játszik szerepet. Az immunszupresszív terápia, a hosszú ideig tartó antibiotikumos kezelés, az újabb betegségcsoportok ...
Kovács, Szilvia
core  

Advanced nanotherapeutics for combating ocular infections: Rational design, antimicrobial mechanisms, and therapeutic breakthroughs

open access: yesBMEMat, EarlyView.
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu   +7 more
wiley   +1 more source

Betametazon hatása a Candida albicans virulenciájára

open access: yes, 2013
Betametazon hatása a Candida albicans virulenciájáragjBiológiaBSc ...
Sipos, Lilla
core  

Antifungal susceptibility tests on Candida albicans, Candida krusei and Candida Paropsilosis

open access: yes, 2020
We tested 2 agents: Amphotericin B and LM1 on the 3 Candida species in vitro conditions, one of the agents was developed in the pharmaceutical chemistry department in University of Debrecen.
Cetinkaya, Abdullah
core  

The power of many: when genetics met yeasts and high‐throughput

open access: yesBiological Reviews, EarlyView.
ABSTRACT In recent years, complex technological capabilities have evolved, driven by the need to solve complex and integrative biological questions through global analyses. New equipment allows the scaling up and automation of processes which previously were carried out on a very limited scale.
Víctor A. Tallada, Víctor Carranco
wiley   +1 more source

Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells

open access: yes, 2019
María J Navarro-Arias,1 Marco J Hernández-Chávez,1 Laura C García-Carnero,1 Diana G Amezcua-Hernández,1 Nancy E Lozoya-Pérez,1 Eine Estrada-Mata,1 Iván Martínez-Duncker,2 Bernardo Franco,1 Hé ...
Garcia-Carnero LC   +8 more
core  

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Investigating the role of Nrg1p and Tup1p during Candida albicans Chlamydospore Formation

open access: yes, 2011
Candidiasis represents the fourth most frequent nosocomial infection both in the US and worldwide. C. albicans is the most common cause of candidiasis which has unacceptably high morbidity and mortality rates and important economic repercussions ...
Williams, Shannon M.
core  

PATHOGENICITY OF CANDIDA [PDF]

open access: yesJournal of Bacteriology, 1961
S, MOURAD, L, FRIEDMAN
openaire   +2 more sources

Cost‐Effective Solid‐State NMR Of Fungal Glucans: A Case Study On Schizosaccharomyces pombe

open access: yesChemistry – A European Journal, EarlyView.
A cost‐effective solid‐state NMR strategy enables replication and semi‐quantitative assessment of inherent variation of the fungal cell wall. Whole cell and cell wall extractions yield subtly different compositional differences, revealing molecular adaptations invisible to microscopy.
Ananya Singh   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy